Diedrich C R, O'Hern J, Wilkinson R J
Clinical Infectious Diseases Research Initiative Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa.
Clinical Infectious Diseases Research Initiative Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa; Royal Hobart Hospital, Tasmania, Australia.
Tuberculosis (Edinb). 2016 May;98:62-76. doi: 10.1016/j.tube.2016.02.010. Epub 2016 Mar 10.
Infection with HIV-1 greatly increases the risk of active tuberculosis (TB). Although hypotheses suggest HIV-1 disrupts Mycobacterium tuberculosis (Mtb) granuloma function, few studies have examined this directly. The objective of this study was to determine what evidence exists about the effect HIV-1 co-infection has upon Mtb granulomas. A systematic search of PubMed, Web of Science, and Medline up to 20 March 2015 was conducted, to identify studies comparing Mtb-infected tissue from HIV-1 infected and uninfected persons, or HIV-1 infected persons with stratified peripheral CD4 T cell (pCD4) counts. We summarized findings that focused on how HIV-1 changes granuloma formation, bacterial presence, cellular composition, and cytokine production. Nineteen studies with a combined sample size of 899 persons were included. Although studies frequently were limited by variable or inadequately described definitions of outcomes and analytical methods, HIV-1 was found to be associated with increased bacillary load within Mtb-infected tissue. Reductions in pCD4 counts within co-infected persons associated with both poorer granuloma formation and higher bacterial load. The high degree of heterogeneity among studies combined with experimental limitations made it difficult to conclusively support previously published and prevalent hypotheses about HIV-1/Mtb co-infection granulomas. To elucidate the validity of these hypotheses we have described areas that can be improved in future studies in order to clarify the influence HIV-1 co-infection has upon the Mtb granuloma.
感染HIV-1会大大增加活动性肺结核(TB)的风险。尽管有假说认为HIV-1会破坏结核分枝杆菌(Mtb)肉芽肿的功能,但很少有研究直接对此进行检验。本研究的目的是确定有哪些证据表明HIV-1合并感染对Mtb肉芽肿有影响。我们对截至2015年3月20日的PubMed、科学网和Medline进行了系统检索,以识别比较HIV-1感染者和未感染者的Mtb感染组织,或具有分层外周血CD4 T细胞(pCD4)计数的HIV-1感染者的研究。我们总结了关注HIV-1如何改变肉芽肿形成、细菌存在、细胞组成和细胞因子产生的研究结果。纳入了19项研究,样本量共计899人。尽管这些研究常常受到结局定义和分析方法多变或描述不充分的限制,但发现HIV-1与Mtb感染组织内细菌载量增加有关。合并感染者pCD4计数的降低与较差的肉芽肿形成和较高的细菌载量相关。研究之间的高度异质性以及实验局限性使得难以确凿支持先前发表的关于HIV-1/Mtb合并感染肉芽肿的普遍假说。为了阐明这些假说的有效性,我们描述了未来研究中可以改进的方面,以明确HIV-1合并感染对Mtb肉芽肿的影响。